X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (12204) 12204
Book Review (5045) 5045
Publication (1193) 1193
Newsletter (517) 517
Book Chapter (204) 204
Newspaper Article (102) 102
Conference Proceeding (57) 57
Book / eBook (36) 36
Magazine Article (18) 18
Transcript (9) 9
Dissertation (6) 6
Reference (2) 2
Trade Publication Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (10273) 10273
humans (9295) 9295
animals (4050) 4050
female (3511) 3511
monoclonal antibodies (3383) 3383
oncology (3148) 3148
antibodies, monoclonal - therapeutic use (2953) 2953
male (2529) 2529
pharmacology & pharmacy (2514) 2514
cancer (2320) 2320
antibodies, monoclonal, humanized (2147) 2147
monoclonal-antibody (2122) 2122
middle aged (1837) 1837
mice (1747) 1747
adult (1679) 1679
treatment outcome (1628) 1628
care and treatment (1606) 1606
antibodies (1534) 1534
aged (1503) 1503
research (1459) 1459
pharmacokinetics (1446) 1446
immunology (1419) 1419
antibodies, monoclonal, humanized - therapeutic use (1359) 1359
therapy (1331) 1331
bevacizumab (1262) 1262
health aspects (1258) 1258
antineoplastic agents - therapeutic use (1251) 1251
antibodies, monoclonal - pharmacokinetics (1244) 1244
antibodies, monoclonal - administration & dosage (1240) 1240
medicine & public health (1224) 1224
drug therapy (1218) 1218
immunotherapy (1212) 1212
clinical trials (1123) 1123
chemotherapy (1104) 1104
antibodies, monoclonal - adverse effects (1068) 1068
analysis (1020) 1020
antibodies, monoclonal - pharmacology (994) 994
proteins (946) 946
clinical trials as topic (935) 935
medicine, research & experimental (932) 932
antibodies, monoclonal, humanized - administration & dosage (918) 918
trastuzumab (910) 910
tumors (894) 894
double-blind (884) 884
safety (884) 884
monoclonal antibody (862) 862
antibodies, monoclonal - immunology (792) 792
cell line, tumor (779) 779
antineoplastic combined chemotherapy protocols - therapeutic use (763) 763
antibody (762) 762
review (759) 759
hematology (757) 757
expression (729) 729
immunoglobulins (728) 728
viral antibodies (723) 723
biotechnology & applied microbiology (712) 712
endothelial growth-factor (704) 704
article (692) 692
antibodies, monoclonal, humanized - adverse effects (686) 686
neoplasms - drug therapy (682) 682
medical research (674) 674
antibodies, monoclonal, humanized - pharmacokinetics (667) 667
efficacy (666) 666
monoclonal-antibodies (659) 659
pharmacology/toxicology (655) 655
breast cancer (641) 641
dose-response relationship, drug (641) 641
breast neoplasms - drug therapy (627) 627
in-vivo (626) 626
biological products (571) 571
metastasis (554) 554
cetuximab (552) 552
pharmacology (544) 544
antineoplastic agents - pharmacology (543) 543
aged, 80 and over (537) 537
internal medicine (531) 531
patients (531) 531
rituximab (531) 531
abridged index medicus (528) 528
biochemistry & molecular biology (524) 524
angiogenesis inhibitors - therapeutic use (514) 514
biomedicine (514) 514
angiogenesis (510) 510
tissue distribution (501) 501
growth-factor receptor (500) 500
vascular endothelial growth factor (498) 498
cancer research (496) 496
trial (494) 494
antibodies, monoclonal, humanized - pharmacology (491) 491
phase-ii trial (490) 490
studies (489) 489
rheumatoid-arthritis (488) 488
vascular endothelial growth factor a - antagonists & inhibitors (479) 479
antineoplastic agents - administration & dosage (478) 478
antineoplastic agents (474) 474
antigens (473) 473
drugs (469) 469
rheumatoid arthritis (463) 463
mice, nude (462) 462
infliximab (457) 457
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (20) 20
Collection Dvlpm't (Acquisitions) - Vendor file (4) 4
Engineering & Comp. Sci. - Stacks (2) 2
Gerstein Science - Circulation Desk (2) 2
Online Resources - Online (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Scarborough Hospital - General (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12978) 12978
German (26) 26
French (21) 21
Japanese (12) 12
Spanish (12) 12
Chinese (7) 7
Italian (4) 4
Danish (3) 3
Polish (2) 2
Russian (2) 2
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
British Journal of Dermatology, ISSN 0007-0963, 02/2016, Volume 174, Issue 2, pp. 296 - 304
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2015, Volume 10, Issue 9, pp. e0137345 - e0137345
CD47 is a widely expressed cell surface protein that functions as a regulator of phagocytosis mediated by cells of the innate immune system, such as... 
TARGET | APOPTOSIS | STEM-CELLS | PROGNOSTIC-FACTOR | MACROPHAGES | MULTIDISCIPLINARY SCIENCES | REGULATORY PROTEIN-ALPHA | CD47 | PROMOTE PHAGOCYTOSIS | CANCER | SYNERGIZES | Phagocytosis - drug effects | Antibodies, Monoclonal, Humanized - therapeutic use | Antineoplastic Agents - immunology | Leukemia, Myeloid, Acute - pathology | Humans | Antibodies, Monoclonal - pharmacokinetics | Macaca fascicularis | Antibodies, Monoclonal - therapeutic use | Antibody Affinity | Antineoplastic Agents - therapeutic use | Leukemia, Myeloid, Acute - immunology | CD47 Antigen - immunology | Haplorhini | Rituximab - therapeutic use | Animals | Antibodies, Monoclonal, Humanized - pharmacokinetics | Leukemia, Myeloid, Acute - drug therapy | Female | Antineoplastic Agents - pharmacokinetics | Mice | Mice, Inbred BALB C | Tumor Cells, Cultured | Antibodies, Monoclonal, Humanized - immunology | Antibodies, Monoclonal - immunology | Monoclonal antibodies | Physiological aspects | Genetic aspects | Research | Non-Hodgkin's lymphomas | Drug therapy | Animal models | Leukemia | Immunoglobulin G | Xenotransplantation | Clinical trials | Stem cell transplantation | Biology | Macrophages | Cancer therapies | Cell surface | Proteins | Signal transduction | Allografts | Xenografts | Primates | Chemical bonds | Bone marrow | Chief executive officers | Drug dosages | Immune system | Medical research | Complementarity | Dendritic cells | Myeloid leukemia | Rituximab | Lymphoma | Immune systems | Medicine | Serum levels | Chemotherapy | Medical prognosis | Stem cells | Solid tumors | Acute myeloid leukemia | Phagocytosis | Cancer | Apoptosis | Tumors | Index Medicus
Journal Article
Nature, ISSN 0028-0836, 08/2016, Volume 537, Issue 7618, pp. 50 - 56
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2012, Volume 30, Issue 8, pp. 837 - 842
Journal Article
British Journal of Dermatology, ISSN 0007-0963, 10/2015, Volume 173, Issue 4, pp. 930 - 939
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2013, Volume 369, Issue 8, pp. 699 - 710
Journal Article
Nature, ISSN 0028-0836, 05/2017, Volume 545, Issue 7652, pp. 60 - 65
Despite the success of monotherapies based on blockade of programmed cell death 1 (PD-1) in human melanoma, most patients do not experience durable clinical... 
CRITERIA | MELANOMA | PEMBROLIZUMAB | IMMUNE CHECKPOINT BLOCKADE | PD-1 BLOCKADE | MULTIDISCIPLINARY SCIENCES | BRAF INHIBITORS | CHRONIC VIRAL-INFECTION | CANCER-THERAPY | IPILIMUMAB | EXHAUSTION | CD8-Positive T-Lymphocytes - cytology | Antibodies, Monoclonal, Humanized - therapeutic use | Melanoma - blood supply | Humans | Ki-67 Antigen - metabolism | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Treatment Outcome | Melanoma - pathology | Phenotype | Antibodies, Monoclonal, Humanized - administration & dosage | Ki-67 Antigen - immunology | Antibodies, Monoclonal, Humanized - pharmacokinetics | Melanoma - immunology | Melanoma - drug therapy | CD8-Positive T-Lymphocytes - metabolism | Female | Programmed Cell Death 1 Receptor - immunology | Antibodies, Monoclonal, Humanized - immunology | CD8-Positive T-Lymphocytes - immunology | Neoplasm Staging | Tumor Burden - immunology | Oncology, Experimental | Melanoma | Physiological aspects | Research | T cells | Tumors | Apoptosis | Cancer | Profiling | PD-1 protein | CD8 antigen | Medical services | Clinical trials | Lymphocytes T | Blood | Metastases | Immunology | Lymphocytes | Immunotherapy | Peripheral blood | Pretreatment | Medical research | Immunoglobulins | T cell receptors | Pharmacology | Patients | Pathology | Cell death | PD-L1 protein | Infiltration | Index Medicus
Journal Article
Journal Article